Article Information
vol. 6 no. 2
Published By
Online ISSN
History
- Received July 26, 2019
- Accepted January 19, 2020
- Published online April 27, 2020.
Copyright & Usage
Copyright ©ERS 2020 This article is open access and distributed under the terms of the Creative Commons Attribution Licence 4.0.
Author Information
- Nicola A. Hanania1⇑,
- Alberto Papi2,
- Antonio Anzueto3,
- Fernando J. Martinez4,
- Kimberly A. Rossman5,
- Christy S. Cappelletti6,
- Elizabeth A. Duncan6,
- Jack S. Nyberg7 and
- Paul M. Dorinsky6
- 1Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, USA
- 2Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, Italy
- 3Pulmonary Medicine and Critical Care, University of Texas Health Science Center and South Texas Veterans Health Care System, San Antonio, TX, USA
- 4Joan and Sanford I. Weill Dept of Medicine, Weill Cornell Medicine, New York, NY, USA
- 5AstraZeneca, Morristown, NJ, USA
- 6AstraZeneca, Durham, NC, USA
- 7Former employee of AstraZeneca, Morristown, NJ, USA
- Nicola Hanania, Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX 77030, USA. E-mail: hanania{at}bcm.edu
Funding
AstraZeneca
Article usage
Altmetrics
Vol 6 Issue 2
Table of Contents
Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD
